Allogene Therapeutics Inc.
04/25/2024 | Press release | Distributed by Public on 04/26/2024 04:07
Notice of Effectiveness - Form EFFECT
Notice of Effectiveness
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | April 25, 2024 4:00 P.M. |
| Form: | S-3 | |||||
|